Sentences with phrase «obesity research by»

In 1994, Jeffrey Friedman, Marilyn M. Simpson Professor and head of Rockefeller's Laboratory of Molecular Genetics, launched a new era in obesity research by discovering a hormone called leptin, which acts on neurons in the brain's hypothalamus region to suppress hunger.

Not exact matches

According to research by the International Journal of Obesity, a cold body's thermoreceptors activate Brown adipose tissue (BAT), known as «good fat,» which in turn burns white fat, «bad fat,» to produce heat.

Ipsos research commissioned by the Australian Beverages Council shows around two - thirds of Australians agree that a tax on soft drinks would be ineffective in reducing obesity and the majority of those surveyed were against the introduction of such a tax.

Media Statement 10 November 2014 Australians don't support another tax on the supermarket trolley latest research shows Ipsos research commissioned by the Australian Beverages Council shows around two - thirds of Australians agree that a tax on soft drinks would be ineffective in reducing obesity and the majority of those surveyed were against the introduction of such a tax.

«Research has shown, most Australian parents agree that programs promoting healthy diet and lifestyle are the most effective way to tackle obesity, followed by nutrition information on packs and vending machines4.

9 April 2014 Media Statement Soft drink tax not the answer for WA The Australian Beverages Council has today slammed Live Lighter's research that a soft drink tax is supported by the public in WA, offering evidence that a tax on beverages has been proven as an ineffective measure to combat obesity, time and time -LSB-...]

Keys and his colleagues, with support from the sugar industry, were effective at discrediting research from around the same time by John Yudkin that sugar, not cholesterol from saturated fats, is the main dietary source of most modern Western culture's obesity, diabetes, and cardiac issues.

The Australian Beverages Council has today slammed Live Lighter's research that a soft drink tax is supported by the public in WA, offering evidence that a tax on beverages has been proven as an ineffective measure to combat obesity, time and time again.

In this systematic review, the researchers investigate whether the disclosure of potential financial conflicts of interest (for example, research funding by a beverage company) has influenced the results of systematic reviews undertaken to examine the association between the consumption of highly lucrative sugar - sweetened beverages (SSBs) and weight gain or obesity.

Funding: This work was supported by the Obesity Policy Coalition and by NHMRC funding for the Centre for Research Excellence in Obesity Policy and Food Systems (APP1041020).

According to the research presented by Dr. Katz, if we don't stop the obesity epidemic, an estimated 42 % of all Americans will be obese in 18 years.

If what we think may be the lifelong benefits for babies of being BLW'd (better eating habits, less risk of obesity etc.) are to be proven — or even disproven — by research, then studies need to define clearly and unambiguously what «true» BLW is.

Providing the scientific foundation and research data, Dr. Ratey has been drafted into the groundswell of those whose mission it is to revitalize schools, combat the obesity crisis, stave off the encroaching epidemic of Sedentarism, by returning to evolutionary principles of physical exercise and proper diet thereby combating syndrome X, the underlying causation of much chronic disease.

Drawing the conclusion that «school lunch in and of itself promotes obesity» from one research paper by an associate professor is preposterous.

A research team led by Jane Heinig at University of California Davis has developed a program called Secrets of Baby Behavior that was designed to give new parents the information they need about infant and breastfeeding norms to reduce unnecessary formula supplementation and to help prevent childhood obesity caused by overfeeding.

Actually, National Breastfeeding Awareness Month is a campaign funded by the US government to encourage women to breastfeed their babies by highlighting the research showing that babies who are breastfed for at least six months are less likely to develop ear infections, diarrhea and childhood obesity.

A review of 7,000 studies by the World Cancer Research Fund found a third of cancers are attributable to diet and found at least six cancers for which obesity was a major risk factor.

Research published yesterday by the Medical Research Council, Human Nutrition Research Centre and the Department of Health found parents fail to respond to the warning signs of childhood obesity.

Commissioned by the Obesity Health Alliance (OHA) the report, entitled «A «Watershed» Moment: Why it's Prime Time to Protect Children from Junk Food Adverts», is based on data collected and analysed by Drs Emma Boyland and Rosa Whalen from the University's Appetite and Obesity research group.

Previous research published by Fenton in 2009 identified the connection between obesity and colon cancer through examining tissue hormones.

Berger's research confirms obesity promotes cancer by multiple simultaneous pathways.

Although caloric intake is still the most important factor in obesity, Gordon's research suggests that the microbiome may play a significant role by affecting the ability to extract energy from food and to deposit that energy as fat.

In the promotional video from Coke's group, linked to by the NYT, exercise scientist Steve Blair says we don't know what is causing obesity and we need more research.

Soda consumers may be getting a much higher dose of the harmful sugar fructose than they have been led to believe, according to a new study by the Childhood Obesity Research Center (CORC) at the Keck School of Medicine of the University of Southern California (USC), part of Keck Medicine of USC.

In an accompanying editorial, Anna Alisi, PhD, of the Liver Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy, and Pietro Vajro, MD, of the Department of Medicine, Surgery and Dentistry, «Scuola Medica Salernitana,» Unit of Pediatrics, University of Salerno, Baronissi (Sa), Italy, commented, «This elegant observational study by Ayonrinde and colleagues is the first epidemiological evidence for the connection between maternal obesity, breastfeeding, and NAFLD.»

I first suspected I might be inhabited by traitors when I read a research paper linking gut bacteria to obesity.

Past research by Olefsky and others has shown that obesity is characterized by low - grade inflammation in adipose or fat tissues and that this inflammatory state can become chronic and result in systemic insulin resistance and diabetes.

However, James notes, a review of data by the World Health Organization's International Agency for Research on Cancer last February concluded that between a quarter and third of all colon, breast, endometrial, kidney, and esophageal cancers globally may trace to excess weight, especially obesity.

Research on microbiome links to obesity, for instance, suggests that a new «skinny» microbiome has to be accompanied by a switch to a diet lower in fat and calories, or else the new microbes will just be outcompeted.

By analyzing genetic samples for over half a million individuals as part of the GIANT research project, which aims to identify genes that regulate human body and size, researchers found more than 100 locations across the genome that play roles in various obesity traits.

In the same study, for those who were sleep deprived, «self - reported hunger and appetite ratings significantly increased by 24 percent and 23 percent, respectively,» noted the authors of the review paper, which was led by Julie Shlisky, a researcher at The New York Obesity Nutrition Research Center at Saint Luke's - Roosevelt Hospital Center.

This study was supported by a VA Merit Grant Award to the Baltimore VA Geriatric Research, Education and Clinical Center and as part of an NHLBI - funded Nutrition Obesity Research Center award.

The study, funded by the National Health and Medical Research Council (NHMRC) of Australia, investigated the body's «famine reaction'to continued dieting and its impact on weight loss in men with obesity.

The Monash University study, led by Emeritus Professor Paul O'Brien and Dr John Wentworth from the Centre for Obesity Research and Education (CORE), has determined that weight loss surgery (gastric banding) for overweight people with diabetes had a profound impact on the illness.

These imaging techniques are behind the high - satisfaction foods Morris is helping to develop at the Institute of Food Research (IFR) in Norwich, UK, which promise to help fight obesity by making people feel full before...

Now Catherine Suter at Victor Chang Cardiac Research Institute in Sydney and her colleagues have investigated the longer - term effects of paternal obesity by mating obese male mice with lean females.

Kravitz has a background in studying Parkinson's disease, and when he began conducting obesity research a few years ago, he was struck by similarities in behavior between obese mice and Parkinsonian mice.

In other research, a knockout of the gene that encodes one type of lncRNA in mice conferred some resistance to obesity caused by a high - fat diet.

Presented by: Arya M. Sharma, MD / PhD, FRCPC, Professor and Chair of Obesity Research and Management at the University of Alberta

«Our society attributes the weight gain and lack of exercise at mid-life (approximately 30 - 60 years) primarily to poor lifestyle choices and lack of will power, but this study shows that there is a genetic program driven by an overactive enzyme that promotes weight gain and loss of exercise capacity at mid-life,» said lead study author Jay H. Chung, Ph.D., M.D., head of the Laboratory of Obesity and Aging Research at the National Heart, Lung, and Blood Institute (NHLBI), part of NIH.

For her research efforts, Dietrich has registered a number of firsts with journal papers reflecting her work on such diverse topics as: improving cancer therapy through odor and taste intervention; prevention and treatment of obesity by drinking more water; health effects of iron and copper in drinking water; and risks to people over 50 for unhealthy over-exposure to iron in water.

«deCODE's success in localizing disease - contributing genetic factors even in such complex disorders as anxiety and obesity marks once more achievements that we believe could not easily be obtained by anyone else,» notes Jonathan Knowles, Head of Global Research at Roche.

The publication of the discovery of leptin by (3) Zhang and Friedman et al (1994) created worldwide interest in this novel peptide as a tool for research and therapeutic discovery for obesity and its related disorders.

Despite our national waistline being touted as a major public health concern — new research, led by Western Sydney University, has found that public hospitals are not adequately resourced to treat the one million adults who currently live with Read more about Study: Australian public hospitals can not meet the rising demand for obesity care - Scimex

Endocrine Society Issues Scientific Statement on Obesity's Causes June 26, 2017 A new Scientific Statement issued by the Endocrine Society calls for more research aimed specifically at understanding the underlying mechanisms that make it difficult to maintain long - term weight loss...

Susan Amara, USA - «Regulation of transporter function and trafficking by amphetamines, Structure - function relationships in excitatory amino acid transporters (EAATs), Modulation of dopamine transporters (DAT) by GPCRs, Genetics and functional analyses of human trace amine receptors» Tom I. Bonner, USA (Past Core Member)- Genomics, G protein coupled receptors Michel Bouvier, Canada - Molecular Pharmacology of G protein - Coupled Receptors; Molecular mechanisms controlling the selectivity and efficacy of GPCR signalling Thomas Burris, USA - Nuclear Receptor Pharmacology and Drug Discovery William A. Catterall, USA (Past Core Member)- The Molecular Basis of Electrical Excitability Steven Charlton, UK - Molecular Pharmacology and Drug Discovery Moses Chao, USA - Mechanisms of Neurotophin Receptor Signaling Mark Coles, UK - Cellular differentiation, human embryonic stem cells, stromal cells, haematopoietic stem cells, organogenesis, lymphoid microenvironments, develomental immunology Steven L. Colletti, USA Graham L Collingridge, UK Philippe Delerive, France - Metabolic Research (diabetes, obesity, non-alcoholic fatty liver, cardio - vascular diseases, nuclear hormone receptor, GPCRs, kinases) Sir Colin T. Dollery, UK (Founder and Past Core Member) Richard M. Eglen, UK Stephen M. Foord, UK David Gloriam, Denmark - GPCRs, databases, computational drug design, orphan recetpors Gillian Gray, UK Debbie Hay, New Zealand - G protein - coupled receptors, peptide receptors, CGRP, Amylin, Adrenomedullin, Migraine, Diabetes / obesity Allyn C. Howlett, USA Franz Hofmann, Germany - Voltage dependent calcium channels and the positive inotropic effect of beta adrenergic stimulation; cardiovascular function of cGMP protein kinase Yu Huang, Hong Kong - Endothelial and Metabolic Dysfunction, and Novel Biomarkers in Diabetes, Hypertension, Dyslipidemia and Estrogen Deficiency, Endothelium - derived Contracting Factors in the Regulation of Vascular Tone, Adipose Tissue Regulation of Vascular Function in Obesity, Diabetes and Hypertension, Pharmacological Characterization of New Anti-diabetic and Anti-hypertensive Drugs, Hypotensive and antioxidant Actions of Biologically Active Components of Traditional Chinese Herbs and Natural Plants including Polypehnols and Ginsenosides Adriaan P. IJzerman, The Netherlands - G protein - coupled receptors; allosteric modulation; binding kinetics Michael F Jarvis, USA - Purines and Purinergic Receptors and Voltage-gated ion channel (sodium and calcium) pharmacology Pain mechanisms Research Reproducibility Bong - Kiun Kaang, Korea - G protein - coupled receptors; Glutamate receptors; Neuropsychiatric disorders Eamonn Kelly, Prof, UK - Molecular Pharmacology of G protein - coupled receptors, in particular opioid receptors, regulation of GPCRs by kinasis and arrestins Terry Kenakin, USA - Drug receptor pharmacodynamics, receptor theory Janos Kiss, Hungary - Neurodegenerative disorders, Alzheimer's disease Stefan Knapp, Germany - Rational design of highly selective inhibitors (so call chemical probes) targeting protein kinases as well as protein interaction inhibitors of the bromodomain family Andrew Knight, UK Chris Langmead, Australia - Drug discovery, GPCRs, neuroscience and analytical pharmacology Vincent Laudet, France (Past Core Member)- Evolution of the Nuclear Receptor / Ligand couple Margaret R. MacLean, UK - Serotonin, endothelin, estrogen, microRNAs and pulmonary hyperten Neil Marrion, UK - Calcium - activated potassium channels, neuronal excitability Fiona Marshall, UK - GPCR molecular pharmacology, structure and drug discovery Alistair Mathie, UK - Ion channel structure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) transobesity, non-alcoholic fatty liver, cardio - vascular diseases, nuclear hormone receptor, GPCRs, kinases) Sir Colin T. Dollery, UK (Founder and Past Core Member) Richard M. Eglen, UK Stephen M. Foord, UK David Gloriam, Denmark - GPCRs, databases, computational drug design, orphan recetpors Gillian Gray, UK Debbie Hay, New Zealand - G protein - coupled receptors, peptide receptors, CGRP, Amylin, Adrenomedullin, Migraine, Diabetes / obesity Allyn C. Howlett, USA Franz Hofmann, Germany - Voltage dependent calcium channels and the positive inotropic effect of beta adrenergic stimulation; cardiovascular function of cGMP protein kinase Yu Huang, Hong Kong - Endothelial and Metabolic Dysfunction, and Novel Biomarkers in Diabetes, Hypertension, Dyslipidemia and Estrogen Deficiency, Endothelium - derived Contracting Factors in the Regulation of Vascular Tone, Adipose Tissue Regulation of Vascular Function in Obesity, Diabetes and Hypertension, Pharmacological Characterization of New Anti-diabetic and Anti-hypertensive Drugs, Hypotensive and antioxidant Actions of Biologically Active Components of Traditional Chinese Herbs and Natural Plants including Polypehnols and Ginsenosides Adriaan P. IJzerman, The Netherlands - G protein - coupled receptors; allosteric modulation; binding kinetics Michael F Jarvis, USA - Purines and Purinergic Receptors and Voltage-gated ion channel (sodium and calcium) pharmacology Pain mechanisms Research Reproducibility Bong - Kiun Kaang, Korea - G protein - coupled receptors; Glutamate receptors; Neuropsychiatric disorders Eamonn Kelly, Prof, UK - Molecular Pharmacology of G protein - coupled receptors, in particular opioid receptors, regulation of GPCRs by kinasis and arrestins Terry Kenakin, USA - Drug receptor pharmacodynamics, receptor theory Janos Kiss, Hungary - Neurodegenerative disorders, Alzheimer's disease Stefan Knapp, Germany - Rational design of highly selective inhibitors (so call chemical probes) targeting protein kinases as well as protein interaction inhibitors of the bromodomain family Andrew Knight, UK Chris Langmead, Australia - Drug discovery, GPCRs, neuroscience and analytical pharmacology Vincent Laudet, France (Past Core Member)- Evolution of the Nuclear Receptor / Ligand couple Margaret R. MacLean, UK - Serotonin, endothelin, estrogen, microRNAs and pulmonary hyperten Neil Marrion, UK - Calcium - activated potassium channels, neuronal excitability Fiona Marshall, UK - GPCR molecular pharmacology, structure and drug discovery Alistair Mathie, UK - Ion channel structure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) transobesity Allyn C. Howlett, USA Franz Hofmann, Germany - Voltage dependent calcium channels and the positive inotropic effect of beta adrenergic stimulation; cardiovascular function of cGMP protein kinase Yu Huang, Hong Kong - Endothelial and Metabolic Dysfunction, and Novel Biomarkers in Diabetes, Hypertension, Dyslipidemia and Estrogen Deficiency, Endothelium - derived Contracting Factors in the Regulation of Vascular Tone, Adipose Tissue Regulation of Vascular Function in Obesity, Diabetes and Hypertension, Pharmacological Characterization of New Anti-diabetic and Anti-hypertensive Drugs, Hypotensive and antioxidant Actions of Biologically Active Components of Traditional Chinese Herbs and Natural Plants including Polypehnols and Ginsenosides Adriaan P. IJzerman, The Netherlands - G protein - coupled receptors; allosteric modulation; binding kinetics Michael F Jarvis, USA - Purines and Purinergic Receptors and Voltage-gated ion channel (sodium and calcium) pharmacology Pain mechanisms Research Reproducibility Bong - Kiun Kaang, Korea - G protein - coupled receptors; Glutamate receptors; Neuropsychiatric disorders Eamonn Kelly, Prof, UK - Molecular Pharmacology of G protein - coupled receptors, in particular opioid receptors, regulation of GPCRs by kinasis and arrestins Terry Kenakin, USA - Drug receptor pharmacodynamics, receptor theory Janos Kiss, Hungary - Neurodegenerative disorders, Alzheimer's disease Stefan Knapp, Germany - Rational design of highly selective inhibitors (so call chemical probes) targeting protein kinases as well as protein interaction inhibitors of the bromodomain family Andrew Knight, UK Chris Langmead, Australia - Drug discovery, GPCRs, neuroscience and analytical pharmacology Vincent Laudet, France (Past Core Member)- Evolution of the Nuclear Receptor / Ligand couple Margaret R. MacLean, UK - Serotonin, endothelin, estrogen, microRNAs and pulmonary hyperten Neil Marrion, UK - Calcium - activated potassium channels, neuronal excitability Fiona Marshall, UK - GPCR molecular pharmacology, structure and drug discovery Alistair Mathie, UK - Ion channel structure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) transObesity, Diabetes and Hypertension, Pharmacological Characterization of New Anti-diabetic and Anti-hypertensive Drugs, Hypotensive and antioxidant Actions of Biologically Active Components of Traditional Chinese Herbs and Natural Plants including Polypehnols and Ginsenosides Adriaan P. IJzerman, The Netherlands - G protein - coupled receptors; allosteric modulation; binding kinetics Michael F Jarvis, USA - Purines and Purinergic Receptors and Voltage-gated ion channel (sodium and calcium) pharmacology Pain mechanisms Research Reproducibility Bong - Kiun Kaang, Korea - G protein - coupled receptors; Glutamate receptors; Neuropsychiatric disorders Eamonn Kelly, Prof, UK - Molecular Pharmacology of G protein - coupled receptors, in particular opioid receptors, regulation of GPCRs by kinasis and arrestins Terry Kenakin, USA - Drug receptor pharmacodynamics, receptor theory Janos Kiss, Hungary - Neurodegenerative disorders, Alzheimer's disease Stefan Knapp, Germany - Rational design of highly selective inhibitors (so call chemical probes) targeting protein kinases as well as protein interaction inhibitors of the bromodomain family Andrew Knight, UK Chris Langmead, Australia - Drug discovery, GPCRs, neuroscience and analytical pharmacology Vincent Laudet, France (Past Core Member)- Evolution of the Nuclear Receptor / Ligand couple Margaret R. MacLean, UK - Serotonin, endothelin, estrogen, microRNAs and pulmonary hyperten Neil Marrion, UK - Calcium - activated potassium channels, neuronal excitability Fiona Marshall, UK - GPCR molecular pharmacology, structure and drug discovery Alistair Mathie, UK - Ion channel structure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) transporters

Apr. 14, 2016 — An international research team that included scientists from Vanderbilt University Medical Center has found a novel way to counteract obesity in mice — by stimulating the growth of blood vessels in fat tissue.

But recent research suggests that the sweet stuff may have a more direct impact: For every additional 150 calories of added sugar downed per person per day, the prevalence of diabetes rose by 1 percent, even after controlling for obesity, physical activity and calories from other foods, according to a large study looking at international data.

A study undertaken by researchers from Birzeit University in Palestine, published in the peer - reviewed Obesity Research and Clinical Practice Journal, put carbonation under the microscope for a period of six months.

His groundbreaking research is leading to new philosophies on how to treat conditions like irritable bowel syndrome, autism, obesity, PTSD, and anorexia by looking at a system of two brains rather than a separate gut and brain.